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ARTICLE
Gating mechanism of elongating β-ketoacyl-ACP
synthases
Jeffrey T. Mindrebo1,2,5, Ashay Patel1,5, Woojoo E. Kim1, Tony D. Davis 1, Aochiu Chen 1,
Thomas G. Bartholow1, James J. La Clair1,2, J. Andrew McCammon1,3, Joseph P. Noel 1,2,4✉ &
Michael D. Burkart 1✉
Carbon-carbon bond forming reactions are essential transformations in natural product
biosynthesis. During de novo fatty acid and polyketide biosynthesis, β-ketoacyl-acyl carrier
protein (ACP) synthases (KS), catalyze this process via a decarboxylative Claisen-like con-
densation reaction. KSs must recognize multiple chemically distinct ACPs and choreograph a
ping-pong mechanism, often in an iterative fashion. Here, we report crystal structures of
substrate mimetic bearing ACPs in complex with the elongating KSs from Escherichia coli,
FabF and FabB, in order to better understand the stereochemical features governing substrate
discrimination by KSs. Complemented by molecular dynamics (MD) simulations and muta-
genesis studies, these structures reveal conformational states accessed during KS catalysis.
These data taken together support a gating mechanism that regulates acyl-ACP binding and
substrate delivery to the KS active site. Two active site loops undergo large conformational
excursions during this dynamic gating mechanism and are likely evolutionarily conserved
features in elongating KSs.
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Fatty acid synthases (FASs) and polyketide synthases (PKSs)iteratively condense and modify ketide units to produce avariety of natural compounds, ranging from fatty acids to
complex bioactive molecules1,2. FASs and PKSs can exist as one or
more polypeptide mega-synthases that contain distinct catalytic
domains (type I) or as discrete enzymes, each possessing specific
activities (type II)3–8. In these pathways, β-ketoacyl ACP synthases,
alternatively ketosynthases (KSs), catalyze carbon–carbon formation
via a precisely choreographed decarboxylative Claisen-like con-
densation to produce a β-ketoacyl species. In fatty acid biosynthesis
(FAB, Fig. 1a), complete reduction at the β-position occurs before
further chain extension, while in polyketide biosynthesis (PKB), the
β-positions of pathway intermediates can be completely, partially,
or not reduced to produce structurally and functionally complex
natural products1,9. The small, 4-α-helical acyl carrier protein
(ACP) is used to shuttle substrates and intermediates to each cat-
alytic domain or discrete enzyme in these pathways10,11. ACPs are
initially translated to an inactive apo form and are subsequently
post-translationally modified to an active holo form via attachment
of a 4′-phosphopantetheine (PPant) arm at a conserved serine
residue, providing a thiol moiety that ligates substrates and pathway
intermediates to the ACP10. Protein–protein interactions (PPIs)
between ACPs and their enzymatic partners (or domains) regulate
the catalytic activities of FASs and PKSs and additionally provide a
mechanism to ensure pathway orthogonality between primary (i.e.,
FAB) and secondary metabolism (i.e., PKB)3,5,6,12–17.
KS-catalyzed carbon–carbon bond formation is an essential
reaction common to both FAB and PKB. The decarboxylative
condensation reaction provides a thermodynamic driving force for
the formation of complex natural products18,19. In addition, KS
domains play an important role in chain length determination,
ensuring product fidelity, and controlling pathway flux15,20,21.
Therefore, efforts to engineer FASs and PKSs will depend on our
ability to manipulate the specificities and activities of these
domains/enzymes, as evidenced by the recent successes engineering
the yeast FAS21–26.
KSs can be classified as elongating or initiating based on their
role within a given pathway. Initiating KSs serve to catalyze the
first condensation reaction of FAB or PKB pathways, converting
holo-ACP to acyl-ACP, while all subsequent condensation reac-
tions are catalyzed by elongating KSs3,4. Despite their distinct
biosynthetic roles, both types of KS operate via a common
ping–pong reaction mechanism, which can be disaggregated into
two discrete steps21,27,28. In the first step, an acyl-ACP associates
with a KS, and its acyl cargo is transferred from the PPant arm to
a conserved, active site cysteine, producing a covalent acyl-KS
adduct and holo-ACP. In the second step, malonyl-ACP replaces
holo-ACP as the KS’s binding partner, subsequently undergoing a
decarboxylative Claisen-like condensation with the acyl-KS
adduct that produces β-ketoacyl-ACP (Supplementary Fig. 1).
During the course of this ping-pong process, two distinct ACPs
must sequentially interact with the KS, and thus must enforce
exquisite temporal and spatial discrimination among the subtly
different chemical states of these acyl-ACPs. The mechanisms
used by KSs to coordinate these two half-reactions and how this
coordination determines substrate specificity remains cryptic
despite extensive biochemical and structural characterization.
The E. coli type II FAS has served as a model system for
understanding ACP-mediated PPIs and FAB19,29–36. Here, we use
this well-characterized system to better understand ACP·KS PPIs
and KS substrate discrimination by structurally characterizing E.
coli elongating KSs, FabB (KASI family KS), and FabF (KASII
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Fig. 1 FAB cycle and known AcpP–PP complexes. a A schematic representation of the chemical transformations that occur during fatty acid biosynthesis,
highlighting the importance of protein–protein interactions required at each step for substrate processing. The four quadrants at the center of the scheme
show the structures of all FAS AcpP crosslinked complexes solved thus far. The top two structures are the crosslinked AcpP–KSs (AcpP–FabF and
AcpP–FabB) reported herein, while depicted below are the crosslinked AcpP–DHs (AcpP–FabZ and AcpP–FabA) solved and reported in previous
publications14,33. Each domain is abbreviated as follows: MAT malonyl-ACP transacylase, KS ketosynthase, KR ketoreductase, DH dehydratase, ER
enoylreductase, and AT acyl transferase. AcpP-DH structures depicted in bottom two quadrants are AcpP–FabZ (PDB: 6N3P), AcpP–FabA (PDB: 4KEH).
b, c Cartoon representations of the crosslinked AcpP–FabB and AcpP–FabF dimers. AcpP is colored cyan; the first KS monomer of AcpP–FabB and AcpP-
FabF is colored orange or light orange, respectively, while the second is colored white in both structures. d Electrostatic potentials (ESP) maps of the FabB
and AcpP monomers. e ESP maps of the FabF and AcpP monomers. In all cases, the ESP is mapped onto the Connelly surfaces of the FabF and AcpP
monomers using a blue to white to red color range, spanning from +15.0 kT·e–1 to –15.0 kT·e–1.
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family KS), as substrate/intermediate complexes with ACP that
approximate states formed during catalysis. In conjunction with
molecular dynamics (MD) simulations and mutagenesis studies,
these structures provide dynamical descriptions of two ACP·KS
complexes, revealing conformational changes that regulate sub-
strate processing. Specifically, we propose that the elongating KSs
employ two conserved active site loops that open and close
through a double drawbridge-like gating mechanism in order to
regulate substrate processing37. When open, the drawbridge
expands the KS active site in order to accommodate PPant-
tethered acyl-AcpP substrates. The structural features underlying
this gating machinery are conserved in related enzymes and
similar conformational transitions will likely determine substrate
selectivity and processing in other FAB and PKB pathways.
Results
Crosslinking and crystallization of AcpP–KS complexes. We
synthesized C12-α-bromo- (1a) and C16-α-bromopantetheine-
amide (1b) and loaded them onto the E. coli ACP (AcpP) using
a one-pot chemoenzymatic method38 to produce crypto-1a-AcpP
(C12AcpP) and crypto-1b-AcpP (C16AcpP) that bear a reactive
warhead on their respective PPant arms38–40 (Fig. 2). These crypto-
AcpPs were then reacted with FabF and FabB to produce uniformly
crosslinked complexes, referred to herein as AcpP–KS, where “-”
denotes a crosslinked complex (Supplementary Figs. 1 and 2). Using
this method, we grew crystals of C12AcpP–FabF and C16AcpP–
FabF and obtained x-ray crystallographic data sets with 2.35 Å and
2.30Å resolution, respectively. The crystallographic asymmetric
units (ASU) of these complexes were identical and contained one
monomer of FabF crosslinked to a single AcpP. In addition,
C12AcpP–FabB crystals diffracted to 1.55Å and C16AcpP–FabB
diffracted to 2.50 Å. The C12AcpP–FabB and C16AcpP–FabB
ASUs both contain the functional FabB dimer crosslinked to two
AcpP molecules (Fig. 2b, c). Additional analysis for the
C12AcpP–FabF and C16AcpP–FabB structures can be found in
Supplementary Notes 1 and 2.
The AcpP–KS interface. The AcpP–KS interacting surfaces are
electrostatic (Fig. 2b–e) and composed largely of flanking charged
and polar groups surrounding a central hydrophobic patch
(Fig. 3). The AcpP and KS monomers provide negatively and
positively charged residues, respectively, to the interface. Figure 3
provides a comparison of the AcpP–FabF and AcpP–FabB
interfaces from this work. While a thorough analysis of the
AcpP–FabB interface was recently performed by Milligan et al.34,
herein we report an example of a KASII-type KS in complex with
an ACP, AcpP–FabF. The AcpP–FabF and AcpP–FabB com-
plexes can be broken into three regions. Region 1 electrostatic
interactions include Lys65, Arg68, and Lys69 of FabF interacting
with Glu13, Gln14, Asp35, and Asp38 of AcpP (Fig. 3a). In
addition, Thr270 of FabF, which sits on a flexible loop that
undergoes conformational rearrangements upon acyl-AcpP
binding, interacts with Asp35 of AcpP. Region 2 interactions
are formed between Arg127, Lys128, and Arg206 of FabF and
Glu47, Glu48, Glu53, and Asp56 of AcpP (Fig. 3b). The central
hydrophobic patch is comprised of interactions between Met44,
Val40, and Leu37 of AcpP and Ile129, Ser130, Pro131, Phe132,
Ala205, and Arg206 of FabF (Fig. 3c).
Comparisons of the AcpP–FabF and AcpP–FabB interfaces
reveal that they share similar chemical features, but structural
alignments of the KS subunits show that the orientations of
AcpPs in the AcpP–KS complexes are distinct (Supplementary
Fig. 3a, b). In FabF, individual ACP monomers, AcpP1 and
AcpP2, bury surface areas of 671.2 Å2 and 675.4 Å2, respectively,
while in FabB, AcpP1, and AcpP2 bury surface areas of 597.5 Å2
and 607.4 Å2, respectively. These small contact areas are
consistent with the transient nature of molecular recognition
between ACP and its binding partners14,33. In addition, the
differences in contact areas of AcpP–FabF and AcpP–FabB
interfaces are consistent with the differing orientations that the
AcpPs adopt relative to their KS partners. It is also worth noting
that when comparing the interfaces of these AcpP–KS complexes,
AcpP’s helix I forms more extensive contacts with FabF than
FabB, while FabB forms more hydrophobic interactions at region
3 (Fig. 3). While the differences at these interfaces are subtle, the
manner in which AcpP engages with each of its cognate KSs may
modulate the activities of FabF and FabB41,42. A time-
resolved analysis of the FabF and FabB interfaces using MD
simulation data is provided in Supplementary Note 3.
Changes in the FabF active site accompany substrate binding.
Electron density maps calculated using the 2.30 Å C16AcpP–FabF
data set demonstrate adequate density for ACP’s Ser36, the PPant
moiety, and acyl cargo. The FabF active site cysteine residue
(Cys163) forms a covalent bond with the α-carbon of the fatty
acid substrate mimetic (1b), and the resulting stereocenter is
found in the S configuration (Fig. 4a). The carbonyl group of the
substrate coordinates to the FabF active site histidine residues,
His303 and His340, in a manner similar to the published struc-
ture of AcpP–FabB34 (PDB: 5KOF) (Fig. 4b). Modeling and
refinement of the crosslinker’s acyl chain required the remodeling
of two active site loops. The first of which is the conserved GFGG
loop (loop 1, residues 399–402) adjacent to the active site that
contains the putative Phe400 gating residue27, and a second less
conserved loop (loop 2, residues 265–275) that caps loop 1
(Fig. 5a). These loops undergo significant conformational chan-
ges, revealing a hydrophobic pocket that accommodates the acyl
chain (Supplementary Fig. 4a–c and Supplementary Note 4). This
pocket is distinct from the substrate binding site identified in the
crystallized acyl-KS intermediate structures 2GFY43 and 1EK444
(Fig. 4c). Close analysis of the C16AcpP–FabF structure indicates
that crystal contacts do not play a role in the conformational
changes seen in these loops.
C16AcpP–FabF adopts an open conformation. A comparison of
the apo-FabF (PDB: 2GFW)43, acyl-FabF (PDB: 2GFY)43,
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and C16AcpP–FabF structures shows that Phe400 of loop
1 moves ~7 Å, as measured by changes in the Phe400 Cα position,
into a pocket revealed by a conformational rearrangement of loop
2 (Fig. 5a). Gly399 and Gly402 of loop 1 act as pivot points as the
loop transitions from a closed conformation to an open con-
formation (Fig. 5b, c). The open conformation is stabilized by a
network of hydrogen-bonding interactions between the backbone
amides of Gly399, Phe400, Gly401, and Gly402 and the side
chains of Asn404 and Asp265 from loop 2 (Fig. 5b, c). Overlays of
the apo-FabF and C16AcpP–FabF structures indicate that the
C16-acyl chain of 1b would clash with Phe400 in the closed
conformation of loop 1 (Fig. 5a). These results indicate that these
loop rearrangements may act as a gate to provide access to the
active site for acyl-ACP substrates. Interestingly, the backbone
amide of Phe400 provides one of the two hydrogen bonds that
form the FabF oxyanion hole when loop 1 assumes the closed
conformation; therefore, the open conformation is likely cataly-
tically inactive.
In apo-FabF, loop 2 rests on top of loop 1 and must undergo a
rearrangement to allow loop 1 to assume the open conforma-
tion. A comparison of apo-FabF to our C16AcpP–FabF structure
demonstrates that loop 2 pivots about a Pro–Pro motif, whereby
Pro273 undergoes a 165° change in its ψ angle, causing the
loop to swing outwards by 5 Å towards the bound AcpP
(Fig. 5d). Analysis of the loop 2 backbone dihedral angles
suggests that the loop transitions from a type VIII β-turn in the
closed conformation to a type I β-turn in the open conforma-
tion. In the closed conformation, loop 2 is stabilized by a
Ser271(O)C-His268(H)N main-chain hydrogen bond, a Thr270-
His268 side-chain hydrogen bond, and a Pro273-Tyr267 C–H π
interaction45 (Fig. 5e, f). Transition to the open conformation
causes the β-turn backbone hydrogen-bonding pattern to
flip from Ser271(O)C-His268(H)N to Ser271(N)H-His268(O)C and
Thr270 breaks its hydrogen bond with His268 to interact with
Asp35 of AcpP.
C12AcpP–FabB trapped in closed acyl transfer conformation.
Analysis of the 1.55 Å C12AcpP–FabB data (Supplementary
Fig. 4d) demonstrates well-resolved electron density for the 4′-
phosphopantetheineamide arm and the C12-acyl chain. In this
structure, loops 1 and 2 are found in a catalytically competent
closed conformation (Fig. 4d–f). Like the catalytic cysteine of
FabF, Cys163 of FabB, reacts stereoselectively with the α carbon
of 1a to produce the S stereoisomer (Fig. 4d). The carbonyl group
of the substrate is coordinated to the oxyanion hole formed by the
backbone amides of Cys163 and Phe400, and the probe’s acyl
chain is positioned inside FabB’s fatty acid binding pocket
(Supplementary Fig. 4d, e). Interestingly, the recently deposited
AcpP–FabB structure (PDB: 5KOF)34 does not feature these
interactions, and instead the carbonyl group forms hydrogen
bonds with His298 and His333.
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Comparison of C12AcpP–FabB and dodecanoyl-FabB (C12-
FabB, PDB: 1EK4)44 demonstrates that the active site and acyl
chain geometries are nearly identical in the two structures (Fig. 4f).
The similarity between the C12-FabB and C12AcpP–FabB
indicates that the latter approximates a catalytically relevant
state for the transfer of substrate from acyl-AcpP to FabB’s active
site cysteine. Both steps of the KS reaction form a tetrahedral
intermediate that is stabilized by the oxyanion hole, which is only
organized when loop 1 and the associated Phe392 residue (Phe400
in FabF), are in the gate-closed conformation.
MSA analysis suggests conservation of loops 1 and 2. Multiple
sequence alignments (MSA) of type II FAS elongating KSs indi-
cate that residues of loop 1 are highly conserved across the KASI
(FabB) and KASII (FabF) families of KSs, while loop 2 is only
conserved within, but not between, the two families (Supple-
mentary Fig. 5). The consensus sequence for loop 1 is comprised
of the conserved GFGG β-turn motif flanked by two conserved
asparagine residues, Asn396 and Asn404 (FabF numbering).
Interestingly, Asn404 interacts with a highly conserved Asp265
found at the start of loop 2 in both the open and closed states,
providing a physical basis for the (proposed) coordinated
movement of loops 1 and 2 (Fig. 5b, c). The conserved nature of
loop 1 and Asp265 suggests that their proposed gating function is
a general feature of type II FAS elongating KSs. Further analysis
and comparison of FabF and FabB structure and function are
provided in Supplementary Note 5.
To determine if these proposed gating elements are conserved
in condensing enzymes outside of type II FAS, we aligned E. coli
FabF with representative KSs from type II PKS, type I FAS, and
type I PKS (Fig. 6a). Loop 1 of FAS and PKS KSs is generally
conserved, although there is modest sequence variation. Notably,
the Phe400 FabF gating residue is conserved in type I FAS and
type II PKS but is replaced by valine or isoleucine in the KS
domains of the type I PKS deoxyerythronolide B synthase
(DEBS). Modification of the gating residue may modulate
substrate specificity, as the KS domains from DEBS accept and
extend substrates with β-substituents and utilize bulkier alpha-
branched extender units, namely methylmalonyl-CoA46.
Loop 2 of these KSs is significantly less conserved than loop 1.
Only Asp265 can be considered highly conserved, as it is present
in all KSs except the KS monomer (actKS) of the heterodimeric
type II PKS KS/chain length factor (CLF) complex from
actinorhodin biosynthesis47,48. In contrast to FAS KSs, these
enzymes iteratively extend a growing polyketide within the KS
binding pocket only unbinding the polyketide once multiple
extensions using malonyl-ACP have been catalyzed to produce a
fully extended poly-β-keto-ACP. The size of the polyketide
produced by actKS is determined by CLF, which accommodates
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the growing polyketide chain, mediating substrate dissociation
when the polyketide intermediate can no longer be accommo-
dated within its binding pocket49. Therefore, given that iterative
type II KSs do not accept acyl-ACPs and instead only process
malonyl-ACPs, these iterative type II KSs may need to disfavor
gating events to prevent premature product off-loading and
ensure the growing polyketide is transferred back to the KS
cysteine after condensation with malonyl-ACP. In actKS, this
may be realized by disfavoring the open conformation of loops 1
and 2, relative to type II FAS KSs, through the substitution of the
negatively charged Asp265 residue of loop 2 with an Asn residue
(Fig. 6a), as the ion·dipole interactions involving Asp265 found in
FabB or FabF are substituted with weaker dipole·dipole interac-
tions in actKS. Interestingly, in KSs from non-iterative type II
polyene PKSs, such as Iga1150,51 and ApeO52, that require
substrate offloading in-between condensation steps52, the same
substitution is not observed, instead these enzymes possess the
conserved Asp265 found in type II FAS KSs.
Mutagenesis studies of FabF gating mutants. To determine if
the proposed gating function of loops 1 and 2 have any effect on
KS activity, we identified a panel of FabF mutations that we
hypothesized would attenuate FabF’s ability to accept and/or
process acyl-AcpP substrates. These mutations were designed to
alter FabF’s proposed gating function by modulating loop 1’s
flexibility (flex modulation), destabilizing (disfavoring) the gate-
open conformation (destabilization), or occluding the pocket
occupied by Phe400 in the gate-open conformation (pocket
blockage). To test this hypothesis, we adapted a crosslinking assay
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Fig. 5 Conformational changes in FabF active site loops. a Comparison of F400, loop 1, and loop 2 conformations of apo-FabF (light grey, PDB: 2GFW43),
dodecanoyl-FabF (light purple, PDB: 2GFY43), and C16AcpP–FabF (light orange, PDB: 6OKG). b Interactions that stabilize the open-conformation of the β-
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that utilizes α-bromo and chloroacrylate mechanistic crosslinkers
with different fatty acid chain lengths as substrate mimetics39
(Fig. 2a). We hypothesized that our panel of FabF gating mutants
would generally retain wild-type (wt) activity toward smaller C2
and C3 chain length crosslinkers, 1c and 2a, but would crosslink
less efficiently with longer C8 and C12 chain length crosslinkers,
2b and 1a, which would require transitions between gate con-
formations to access the KS active site.
Before assaying these gating mutants, we first evaluated the
crosslinking activity of a gate removal mutant, F400A. The results
show that both F400A and wt FabF crosslink with generally equal
efficiency with short- and long-chain acyl-AcpP substrates
(Fig. 6). Interestingly, the F400A mutant underwent crosslinking
with the C8Cl (2b) with higher relative efficiency to wt (133%)
both in our single time point assay and at a faster rate in our
time-course crosslinking studies (Supplementary Figs. 6–11).
These results suggest that mutating Phe400, a key gating
residue27, to alanine enhances the accessibility of probe to the
KS active site cysteine27. In addition, we prepared two FabF
interface mutants, K65E and K65A/K69A, to demonstrate that
crosslinking can also report on PPIs. Both of these mutants
showed reduced crosslinking towards all probes, but crosslinking
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efficiency was most significantly reduced with long-chain cross-
linkers (Fig. 6). These results suggest that well-coordinated PPIs
are important for chain-flipping53 substrates into the KS
active site.
To prevent loop 1 transitions from the closed to open
conformation, we mutated FabF’s Gly310 to a phenylalanine or
methionine residue to introduce a bulky amino acid at a position
that would occlude the pocket occupied by Phe400 in the open
conformation (pocket-blockage, Supplementary Fig. 12). Inter-
estingly, G310F and G310M crosslink with 73 and 70% efficiency
with C2αBr (1c) but only 33 and 30% efficiency with C12αBr
(1a), respectively. Differential crosslinking activity between short
and long substrates was more pronounced for the chloroacrylate
crosslinkers as G310F and G310M crosslinked with 85 and 82%
efficiency with C3Cl (2a) but only 5 and 1% efficiency with C8Cl
(2b), respectively (Fig. 6). These results indicate that blocking the
open conformation reduces FabF’s ability to accept longer acyl-
ACP substrates but not that of smaller substrates that more
closely resemble malonyl-AcpP.
Similar patterns emerge when examining the crosslinking
efficiencies of our D265A and D265N mutants of loop 2. These
mutants are hypothesized to disfavor the open conformation by
replacing the ion·dipole interactions involving the conserved
Asp265 from loop 2 with weaker interactions. These mutations
should therefore disrupt the conserved D265 coordinated
hydrogen-bonding network between loops 1 and 2 that stabilizes
the open conformation. D265A and D265N mutants crosslinked
with 72 and 77% efficiency with C2αBr (1c) and 51 and 64%
efficiency with C12αBr (1a), respectively. Furthermore, D265A
and D265N crosslinked with 63 and 73% efficiency with C3Cl
(2a) but only 2 and 1% efficiency with C8Cl (2b), respectively.
In contrast, loop flexibility-modulated mutants, G399A and
G402A, did not demonstrate pronounced differences in cross-
linking relative to wt FabF in our assay. The G399A mutant
reacted with all crosslinkers with similar efficiency as wt FabF,
while crosslinking efficiencies of the G402A mutant only showed
differential crosslinking activity when comparing C3Cl (2a)
(87%) and C8Cl (2b) (24%) (Fig. 6). G399A also crosslinked
similarly to wt FabF in our time-course crosslinking assay (Fig.
S5). While it was expected that the G399A mutant would show a
difference in crosslinking efficiency, it is important to note that
such a substitution is observed in nature, as the KSs from type II
polyene synthases, Iga1150,51 and ApeO52, both have alanine at
this position (Fig. 5a). In addition, the dihedral angles of G399A
in both the closed and open conformation are not in the
Ramachandran forbidden zone (Fig. 5b, c) and can therefore be
reasonably accessed by the G399A mutant.
MD simulations support a KS gating mechanism. Using these
AcpP–KS crystal structures as initial coordinates, we performed
MD simulations of C10, C12, and C16-AcpP·KS complexes,
where “·” denotes a noncovalent complex (Supplementary Figs. 1
and 13), to probe the dynamic properties of the gating processes
in acyl-AcpP·KS complexes. Models of the ACP-bound acyl-
AcpP·KSs were constructed by manually replacing the cross-
linkers present in the crystal structures with the natural saturated
substrates encountered by the KSs (Online Methods). In addition,
simulations of apo-FabB and apo-FabF were performed using
previously reported crystal structures (PDB: 2VB954 and
2GFW43, respectively) as initial coordinates. Lastly, in an attempt
to computationally visualize the transition between the open and
closed conformations of loops 1 and 2, we performed additional
MD simulations of apo-FabF and apo-FabB using KS structures
prepared by removing the AcpP monomers from the AcpP–KS
complexes reported herein. We distinguish these structures from
the crystallographic apo-FabB and apo-FabF structures by refer-
ring to them as apo-FabB* and apo-FabF*. Because these apo-
structures feature their loops in conformations that may not be
stable in the absence of an associated acyl-ACP, we hypothesized
that they may more readily undergo conformational transitions.
Each of the ten systems described above was subjected to three
independent 500 ns MD simulations. Replicates were initiated
using different velocities and a total of 15 μs of MD data were
collected. General analysis for all simulated systems is provided
in Supplementary Figs. 14–27 and additional discussion regar-
ding substrate interactions is provided in Supplementary Notes 6
and 7.
From this data, no transition between the closed and open loop
conformations was sampled during the course of any simulation,
suggesting that the coordinated movement of loops 1 and 2
between their open and closed states is a relatively slow process,
likely occurring on timescales of tens or hundreds of μs55.
Nonetheless, analysis of the per residue backbone and side chain
root mean square fluctuations (RMSFs) of the loop residues,
shown in Fig. 7d–i and Supplementary Figs. 28–30, suggests the
following: Firstly, while the loops of apo-FabB and apo-FabF have
similar RMSFs, the loops of apo-FabF* and the acyl-AcpP·FabF
complexes show greater fluctuations than do those of apo-FabB*
and the acyl-AcpP·FabB complexes, respectively. Of the structures
shown in Fig. 7d–i, apo-FabF* is the most significant. RMSF
analysis shows that loop 2 of apo-FabF* fluctuates more in this
structure than any other simulated structures. Despite this
dynamism, apo-FabF*’s loop 1 remains fairly rigid. It is possible
that the transition of loop 2 from its open to closed conformation
first requires the motion of loop 1 toward the active site. In fact,
this movement of loop 1 would restore the oxyanion hole absent
in the C16AcpP–FabF structure (Fig. 3). Therefore, the large
RMSFs observed for apo-FabF*s loop 2 reveal a so-called
frustrated loop unable to assume its preferred open conformation
in the absence of acyl-AcpP (Fig. 7). These findings, along with
published studies of PKS ACPs16, suggest that ACPs may not
only be responsible for substrate delivery but also may induce
loop motions that promote catalysis through allostery.
Identification of this frustrated loop suggests that the motions
of loops 1 and 2 are correlated. To evaluate this hypothesis, we
determined the average correlations of the motions of residues of
loops 1 and 2 sampled during the course of the MD simulations
of apo-KS, apo-KS*, and acyl-AcpP·KS structures. Both FabB and
FabF appear to form the same general network of interloop
interactions to choreograph loop motion (Fig. 8). Nonetheless,
the co-relatedness of the loops are distinct in the open (Fig. 8c, e)
and closed (Fig. 8a–d) states, with a greater correlation found in
the closed conformation. Furthermore, the average correlation
of loop 1 and 2 residues is slightly greater in simulations of
acyl-AcpP·FabF complexes than simulations of either apo-FabF
or apo-FabF*. On the basis of this analysis, it is evident that loops
1 and 2 move in concert with one another and that the GFGG
hinge motif is found to be most correlated to the highly conversed
Asp265 residue of loop 2. Interestingly, these motifs are more
highly correlated in FabF than in FabB, although higher positive
average correlations between Asp265 and intra-loop 2 residues
Pro271, Ser272, and Gly273 are observed in simulations of apo-
FabB and its acyl-AcpP complexes.
The residues of loop 1 and 2 of FabB and FabF, regardless
of enzyme state, that are most strongly correlated are residues of
the GFGG motif of loop 1 and Asp265 of loop 2. In fact, the
closed and open conformations of these loops can be clearly
distinguished by differences in these intra- and interloop
interactions. That we do not observe changes in these networks
of interactions within any KS simulation indicates the stability of
the open and closed states. According to simulation data, the
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open conformation (apo-FabF* and acyl-AcpP·FabF) is char-
acterized by hydrogen-bonding interactions involving the GFGG
motif and Asp265 and Asn404. Namely, Gly399 forms a
hydrogen bond with Asn404 while the negatively charged
Asp265 residue simultaneously coordinates Asn404 and the
backbone amides of all residues of the GFGG motif. In the open
conformation of FabF, average distances of 5.09 Å, 3.91 Å, 3.66 Å,
and 4.12 Å, respectively, are computationally observed between
the center of mass of the carboxylate moiety of Asp265 and the
backbone amide nitrogens of Gly399, Phe400, Gly401, and
Gly402 (Fig. 9). Given the highly conserved nature of Asp265 and
its substitution with a less potent hydrogen-bond acceptor (e.g.,
Asn265 in actKS) in iterative type II KSs, it is reasonable to
postulate that the coordination of the motion of loop 1 and loop 2
is mediated by Asp265.
Discussion
KSs catalyze multi-step reactions that require the association and
dissociation of two distinct acyl-AcpPs and involve the inter-
mediacy of an acyl-enzyme adduct. Enzymes that catalyze such
complex chemical transformations often implement gating
mechanisms to control solvent access, exert mechanistic selec-
tivity, and/or control reaction order37. Zhang et al. previously
showed that Phe400 of Streptococcus pneumoniae FabF (SpFabF)
acts as a KS gating residue27. The F400A mutant of SpFabF has
reduced catalytic activity relative to wt for its native reaction, but
efficiently produces triacetic acid lactone, a common shunt pro-
duct of condensing enzymes that results from the mispriming and
extension of malonyl-ACP. These results suggest a compromised
gating system that no longer controls reaction order. The pro-
posed gating role of Phe400 is also supported with previously
published structural data27,43,56. In structures of apo-FabB and
apo-FabF, Phe400 initially blocks access to the active site cysteine
but after transacylation rotates away to form the malonyl-ACP
binding site for the pong half-reaction27,43,56.
Results reported herein not only confirm and build upon the
role of Phe400 as a KS gating residue but also provide additional
context for its mechanism and regulation. With this information,
we propose that elongating KSs use a double drawbridge-like
gating mechanism37 to direct substrate binding and control the
timing and sequence of the transacylation and condensation half-
reactions. From this study we propose the model shown in
Fig. 10. Here, ACP binds to apo-KS, upon which ACP chain-
flips53 its cargo into the KS active site as KS loops 1 and 2 move in
a coordinated manner to assume an open conformation, forming
a transient, hydrophobic delivery/extraction pocket that tem-
porarily accommodates the substrate (Fig. 10b). Loops 1 and 2
then return to their closed conformations, directing the sub-
strate’s acyl chain into the acyl binding pocket while simulta-
neously restoring the oxyanion hole that facilitates transacylation
(Fig. 10c). Upon transacylation, holo-ACP dissociates and Phe400
rotates to form the malonyl-ACP binding pocket22 (Fig. 10d).
The proposed gating mechanism coordinated by loops 1 and 2
is in agreement with our mutagenesis studies, MD simulations,
and MSA analysis. FabF pocket-blockage mutants, G310M and
G310F, and loop 2 destabilization mutants, D265A and D265N,
show reduced crosslinking with long-chain acyl-AcpP substrates
as compared with short-chain substrates. These results, taken
together, indicate that blocking transitions to the gate-open
conformation or disfavoring the gate-open conformation by
disruption of the the interloop interaction network inovl-
ving impairs KS activity with acyl-AcpPs. Interrogation of these
trapped catalytic states using long time-scale MD simulations
demonstrates that the open and closed conformations of FabF are
stable and coordinated by a conserved network of hydrogen-
bonding interactions. Furthermore, this network of interactions
serves to correlate the motions of loops 1 and 2 and is generally
conserved in elongating KSs in type I PKS, type I FAS, and type
II PKS.
Given our gating model (Fig. 10), we now propose a general
mechanism used by these synthases to regulate substrate processing
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Fig. 8 Average cross correlations of the motions of key loop 1 and 2 residues sampled computationally. Cross correlations were determined by
computing a motion vector for each residue of loop 1 and loop 2 from its prior position to its current over the course of each simulation. In this manner,
motion vectors for each pair of residues of loop 1 and 2 are calculated for each frame of simulation data. Heat maps generated from the cross-correlation
analysis of the motions of loop 1 and 2 residues of a apo-FabF, b apo-FabB, c apo-FabF*, d apo-FabB*, e acyl-AcpP·FabF, and f acyl-AcpP·FabB, respectively,
sampled using molecular dynamics (MD) simulations. a The heat map has been divided into four quadrants; quadrants II and III illustrates cross
correlations of the motions of residues within loops 1 and 2, respectively. Inter-loop cross correlations are shown in quadrants I and IV. Note that each
heatmap is symmetric about the diagonal that bisects quadrants II and III.
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and catalysis. Transition to the open-conformation disrupts the
oxyanion hole, which suggests that (trans)acylation of the active site
cysteine occurs after the gate adopts the closed conformation.
Consequently, the gate could act as a sensor that only reorganizes
the oxyanion hole when the correct substrate is bound. Therefore,
the gate and F400 may prohibit FAS KSs from reacting with fatty
acyl intermediates that are not appropriate condensation substrates
(i.e., β-hydroxy-acyl-ACPs).
A careful consideration of loops 1 and 2 and their potential
specific functions reveals some interesting insights as well.
Ramachandran analyses of the GFGG motif’s fluctuations over
the course of MD simulations illustrate the rigidity of loop 1 in
both the closed and open conformations. The φ and ψ angles of
the GFGG residues sampled computationally are narrowly dis-
tributed with hinge residues, Gly399 and Gly402, possessing
distinct backbone dihedral angles in the open and closed con-
formations (Fig. 5b, c). This is in contrast to Ramachandran
analysis of the hinge residues in loop 2, which shows that
although the φ and ψ angles of Pro272 and Pro273 are distinct in
the open and closed states in our crosslinked structures, they
sample similar φ, ψ angle distributions during simulations
(Fig. 5e, f and Supplementary Figs. 31 and 32). These results,
along with the increased sequence variation in different con-
densing enzyme families, suggests loop 2 may modulate loop 1
gating events, potentially conferring different activities or sub-
strate specificities to distinct KSs. This is an appealing hypothesis,
as loop 2 sits on top of loop 1, effectively capping it in when in the
closed conformation. Furthermore, the dynamism of loop 2 in
our apo-FabF* simulations indicates that acyl-AcpP substrates
stabilize the gate-open conformation. In fact, AcpP binding or the
chain flipping of acyl cargo into the KS active site may serve to
trigger gating events by stabilizing loop 2’s open position.
Movement of loop 2 would thereby allow loop 1 to assume the
gate-open conformation, raising the drawbridge and allowing
substrate access to the active site. While more work is needed to
test this hypothesis, a recent study by Robbins et al. demonstrated
that mutation of S315A from loop 2 of DEBS KS1 increased the
formation of propionate, which results from the decarboxylation
of the methylmalonyl-ACP substrate57. These findings suggest an
important role for loop 2 residues in DEBS and that the altered
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Fig. 9 Analysis of the fluctuations of inter-loop hydrogen bonding networks. Histograms showing the distances between the hydrogen-bond donating
Asp265 and highly conversed (hydrogen-bonding accepting) resudes, Gly399, Phe400, Gly401, Gly402, and Asn404 sampled computationally.
Histograms of these distances sampled in molecular dynamics (MD) simulations of a apo-FabF, b apo-FabB, c apo-FabF*, d apo-FabB*, e acyl-AcpP·FabF,
and f acyl-AcpP·FabB, respectively.
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S315A mutant activity may be indicative of an impaired gating
system.
The importance of KS-catalyzed carbon–carbon bond forma-
tion in biosynthetic pathways cannot be overstated. These
enzymes perform complex reactions and employ poorly under-
stood biochemical regulatory mechanisms to ensure substrate
specificity and product fidelity. Here, the combination of che-
mical, structural, and computational biology together support a
gating mechanism used by elongating KSs to recognize and
process acyl-ACP substrates. These results provide broadly
applicable insights into KS activity, function, and substrate
selectivity as well as further our understanding of the E. coli AcpP
interactome.
Methods
Ketosynthase production, purification, and tag cleavage. The N-terminal His8-
tag FabF and FabB recombinant proteins were expressed in E. coli BL21 and
cultured in Terrific Broth (MilliporeSigma). Cells were grown in the presence of
50 mg·L–1 kanamycin, induced with 0.5 mM Isopropyl β-d-1-
thiogalactopyranoside (IPTG) at OD600= 0.8, and incubated at 37 °C for 4 h. The
cells were spun down by centrifugation at 500 × g for 30 min and the collected
pellets were resuspended in lysis buffer (50 mM Tris, 150 mM NaCl, 10% glycerol,
pH 8.0) along with 0.5 mg·mL–1 lysozyme (Worthington Biochemical Corp).
The pelleted cells were lysed by sonication (4 s pulses for 5 min), followed by
another centrifugation at 17,400 × g for 30 min to clear the lysate. The proteins
were purified using Ni-NTA resin (Thermo) in the column and were washed
sequentially with wash buffer (50 mM Tris, 150 mM NaCl, 10% glycerol, pH 8.0)
followed by elution with 250 mM buffered imidazole. The His8-tags of purified
proteins were cleaved with bovine thrombin (2 U per 1 mg protein) for 16 h at 6 °C
while dialyzing against the dialysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 10%
glycerol, 0.5 mM TCEP). Resulting solutions were re-purified using Ni-NTA resin
(Thermo Fisher Scientific) to trap the un-cleaved proteins. The FabF and FabB
were further purified by FPLC using the HiLoad Superdex 200 (GE Biosciences)
size exclusion column. The eluted proteins were collected and concentrated to 2–4
mg·mL–1 using Amicon Ultra Centrifuge Filters (MilliporeSigma) with 10 kDa
molecular weight cut off.
Native AcpP recombinant protein purification. Native AcpP recombinant pro-
tein was expressed in E. coli BL21 (DE3) and grown in Terrific Broth (Source).
Cells were grown at 37 °C in the presence of 100 mg·L–1 ampicillin, induced with
0.5 mM IPTG at OD600= 0.8, and incubated at 18 °C for 16 h. The cells were spun
down by centrifugation at 500 × g for 30 min, and the collected pellets were
resuspended in lysis buffer (50 mM Tris, 5% glycerol, pH 7.4) along with 0.1
mg·mL–1 lysozyme (Worthington Biochemical Corp). The pelleted cells were lysed
by sonication (4 s pulses for 5 min). Due to the high stability of AcpP, irrelevant
proteins were precipitated by dripping in same volume of isopropanol into the
lysate at the speed of 0.1 mL·s–151. The resulting mixture was spun down by
centrifugation at 11,200 × g for 1 h and the supernatant was injected directly into
FPLC. AcpP was purified by HiTrap Q HP anion exchange chromatography col-
umn in 50 mM Tris buffer with a gradient of NaCl from 0M to 1M and the native
AcpP eluted around 0.3 M NaCl. The eluted protein was collected and con-
centrated using Amicon Ultra Centrifuge Filters (Millipore) with 3 kDa molecular
weight cut off.
Holo-AcpP apofication and apo-AcpP purification. The purified protein was
resulted in a mixture of holo-AcpP and apo-AcpP. The phosphopantetheine moiety
on holo-AcpP was removed by acyl carrier protein hydrolase (AcpH) in lysis buffer
for 16 h58. Final reaction concentrations: 5 mg·mL–1 AcpP mixture, 0.01 mg·mL–1
AcpH, 50 mM Tris (pH 7.4), 10% glycerol, 10 mMMgCl2, 5 mMMnCl2, and 0.25%
DTT. The resulting pure apo-AcpP, was analyzed by conformationally sensitive
urea PAGE (2.5 M urea), and further purified by FPLC using HiLoad 16/600
Superdex 75 PG (GE Biosciences) size exclusion column to remove AcpH. The
eluted protein was collected and concentrated using Amicon Ultra Centrifuge
Filters (Millipore Sigma) with 3 kDa molecular weight cut off.
Apo-AcpP loading and crypto-AcpP purification. All crosslinkers were loaded
onto apo-AcpP using a one-pot chemoenzymatic method38. This method utilizes
three CoA biosynthetic enzymes (CoaA, CoaD, CoaE) to form CoA analogues and
a phosphopantetheinyl transferase (PPTase, Sfp) to load them onto apo-AcpP,
resulting in crypto-AcpP. Final reaction concentrations: 1 mg·mL–1 apo-AcpP,
0.04 mg·mL–1 Sfp, 0.01 mg·mL–1 CoaA, 0.01 mg·mL–1 CoaD, 0.01 mg·mL–1 CoaE,
50 mM potassium phosphate pH 7.2, 12.5 mM MgCl2, 1 mM DTT, 0.2 mM pan-
tetheineamide probe (1a,1c or 2a,2b) (Fig. 2), and 8 mM ATP. The stock solutions
of crosslinkers 1a-1c, 2a, and 2c were prepared by dissolving them in DMSO to a
final concentration of 50 mM. Reactions were incubated at 37 °C for 16 h and then
purified by HiLoad Superdex 75 (GE Biosciences) size exclusion column. The
eluted protein was collected and concentrated using Amicon Ultra Centrifuge
Filters (Millipore Sigma) with 3 kDa molecular weight cut off up to a concentration
at 1–3 mg·mL–1.
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Crosslinking reaction and crosslinked complex purification. The crosslinking
reactions were carried out by mixing crypto-AcpP with its partner protein (FabF or
FabB) in 5:1 ratio at 37 °C for 16 h. Reactions were examined by 12% SDS PAGE
and purified by HiLoad 16/600 Superdex 200 PG (GE Biosciences) size exclusion
column using minimal buffer (20 mM Tris, 50 mM NaCl, pH 7.4). The resulting
protein complex was greater than 95% in purity, determined by SDS PAGE, and
was concentrated to 8–10 mg·mL–1 using Amicon Ultra Centrifuge Filters (Milli-
poreSigma) with 30 kDa molecular weight cut off. The concentrated crosslinked
complex was immediately used for protein crystallization or flash-frozen and
stored in −80 °C freezer for later use.
Construction of ketosynthase mutants. Ketosynthase mutants were generated
using the site directed mutagenesis method developed by Liu and Naismith59. All
constructs were verified via Sanger sequencing (Eton Bioscience Inc.). Primers used
for mutagenesis can be found in Supplementary Fig. 33.
Crosslinking assay. Each reaction was set up to contain 40 μM of crypto-AcpP,
20 μM of FabF, and buffer (25 mM Tris, 150 mM NaCl, 10% glycerol, 0.5 mM
TCEP, pH 7.4). To stop the reaction at the designated time point, 2.5 μL of the
reaction solution was mixed with 10 μL of 3X SDS dye. Samples were analyzed by
12% SDS-PAGE and the intensity of protein bands was measured by ImageJ60. The
crosslinking efficiency was calculated by [(Icrosslink)/(Icrosslink+ IFabF)] × 100%
where “I” stands for band intensity. All reactions were performed in biological
triplicate and the crosslinking efficiency of mutants was normalized to the average
wild type crosslinking efficiency to obtain a normalized relative crosslinking effi-
ciency. The plotted data represent the average normalized crosslinking efficiency of
each mutant and the error bars are represented as standard deviation (±SD).
General synthetic methods. General synthetic methods are provided in Supple-
mentary Note 8 and NMR characterization of compounds and intermediates is
provided in Supplementary Figs. 40–43.
Crystallization, structure determination, and refinement. The crystals of the
crosslinked complexes were grown by vapor diffusion at 6 °C. In detail, 1 μL
of crosslinked complex (8–10 mg·mL–1) was mixed with 1 μL of corresponding
crystallographic condition and the mixture was placed inverted over 500 μL of the
well solution (hanging-drop method). The AcpP–FabF complexes crystallized in
26–30% PEG 8 K, 0.1 M sodium cacodylate pH 6.5, and 0.3 M NaOAc, yielding
numerous orange rods amongst a heavy precipitate. Seeding trials were performed
to increase size and quality of the samples. The C12AcpP–FabB complexes pro-
duced crystals in two conditions: 20% PEG 8 K, 0.2 M Mg(OAc)2, 0.1 M sodium
cacodylate pH 6.5 as well as 30% PEG 8 K, 0.2 M (NH4)2SO4, 0.1 M sodium
cacodylate, pH 6.5. Both conditions yielded square plates and required 1–2 weeks
for complete growth of crystals. The C16AcpP–FabB complexes produced crystals
in 18–24% PEG 8 K, 0.1 M sodium cacodylate, and 0.3 M NaOAc, pH 6.5.
All data were collected at the Advanced Light Source synchrotron at Berkeley.
Data were indexed using iMosflm61 then processed and scaled using aimless from
the CCP4 software suite62,63. Scaled reflection output data were used for molecular
replacement and model building in PHENIX64. For AcpP–FabF complexes, phases
were solved using molecular replacement by first locating the larger FabF (PDB:
2GFW43) monomer followed by a second search function to place the smaller
AcpP (PDB: 2FAC65) molecule in the residual density. For C12AcpP–FabB and
C16AcpP–FabB complexes, initial phases were solved using molecular replacement
by first performing a search function using the FabB monomer (PDB: 1G5X30) and
then manually placing the AcpP molecules in the residual electron density. The
parameter file for the covalently bonded 4′-phosphopantetheine was generated
using Jligand (CCP4)63. Manually programmed parameter restraints were used to
create the associated covalent bonds between 4′-phosphopantetheine to Ser36 and
Cys163 during refinement. These parameters are provided in the parm-file folder
located in the Source Data file.
Preparation of apo-KS structures for MD simulations. Simulations of apo-FabB
and apo-FabF were performed using two sets of initial coordinates: one derived
from previously reported 1.55 Å apo-FabB (PDB: 2VB954) and 2.40 Å apo-FabF
(PDB: 2GFW43) and a second set generated by modifying the crosslinked struc-
tures of E. coli AcpP–FabB and AcpP–FabF reported herein by deleting coordinates
corresponding to atoms from AcpP.
Preparation of acyl-AcpP·KS structures for MD simulations. The crosslinked
structures of E. coli AcpP–FabB and AcpP–FabF reported herein were used to
prepare the initial coordinates used to perform MD. The asymmetric unit of the
AcpP–FabF structure is—unlike that of crosslinked AcpP–FabB—the 1:1
AcpP·FabF complex. In order to prepare coordinates for the (functional) bio-
logical unit, AcpP2·FabF2, the asymmetric unit of the AcpP1–FabF1 structure was
rotated about the twofold symmetry axis of the AcpP–FabF biological unit. The
2:2 complexes of acyl-AcpPs shown in Scheme S1 and either FabB or FabF were
constructed by manually modifying the chemical crosslinker present the
experimental structures. Modifications of this moiety were performed using
Avogadro 1.1.166 [http://avogadro.cc/], Gaussview 5.0.9, and Pymol v.1.8.6, and
Pymol v.2.2.3. Schrodinger was used to add poorly resolved C- and N-terminal
residues omitted in the dimeric AcpP·FabB and AcpP·FabF complexes. The
protonation state of titratable residues in the apo-KSs and acyl-AcpP·KS dido-
mains were assigned using the H++ webserver, with the exception of the active
site Cys163 of FabB and FabF; this residue was simulated in as a thiolate67–70.
Histidine protonation states were inspected manually.
Parameter generation for acyl-AcpP. For each simulated AcpP·KS complex, the
acyl substrate, phosphopantetheine cofactor, and the conserved serine residue of
AcpP to which the cofactor is affixed were treated as a single nonstandard residue.
AMBER (ff14SB71) and GAFF72 type force field parameters were assigned to the
atoms of these nonstandard residues using ANTECHAMBER73. Partial charges for
all atoms in all nonstandard residues were determined using the RESP metho-
dology74. All quantum calculations were performed using Gaussian 09 (https://
gaussian.com/glossary/g09/).
Preparation of simulation cells. Proteins were solvated in a water box with
TIP3P75 water molecules. Using TLEAP76, the simulation cell was constructed such
that its edges were placed 10 Å away from the closest proteinogenic atom. TLEAP
was used to neutralize and salt the water box to mimic physiological conditions
(0.15 M). Counterions (Na+ and Cl–) were also added to the simulation cell
randomly.
Simulation details. Amber16 and Amber1876 were used to perform all MD
simulations. All simulations were performed using the ff14SB71 and GAFF72 force
fields. A 2 fs time-step was utilized via the SHAKE algorithm, which constrains all
nonpolar bonds involving hydrogen atoms77. Long-range electrostatic interactions
were treated using the Particle Mesh Ewald (PME) method with a 10 Å cutoff for
all non-bonded interactions78. Both solvated protein complexes were energy
minimized in a two-step fashion. In a first step, solvent molecules and counterions
were allowed to relax, while all protein atoms were restrained using a harmonic
potential (k= 500 kcal mol−1 Å–2). This geometry optimization was followed by an
unrestrained energy minimization of the entire system. The thermal energy
available at a physiological temperature of 310 K was slowly added to each system
over the course of a 3.5 ns NVT ensemble simulation. The solvated complexes were
then subjected to unbiased isobaric–isothermal (NPT) simulations for 25 ns in
order to equilibrate the heated structures. Three independent 500 ns production
MD (NPT ensemble) of each system were performed with different initial velo-
cities. For both NVT and NPT simulations, the Langevin thermostat (λ= 5.0 ps–1)
was used to maintain temperature control79. Pressure regulation in NPT simula-
tions (target pressure of 1 atm) was achieved by isotropic position scaling of the
simulation cell volume using a Berendsen barostat.
Analysis and visualization of simulation data. Analysis was performed using
CPPTRAJ Version V4.14.0 (AmberTools V19.00), PYTRAJ v2.02.dev0, a Python
front-end for the CPPTRAJ analysis code, and MDTRAJ v1.9.380,81. Trajectories
were visualized using VMD 1.9.482 and Pymol v1.8.6 and Pymol v2.2.3. Coordinate
data were written to disk every 10 ps.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All crystallographic models and data were submitted to the Worldwide Protein Data
Bank (wwPDB, www.wwpdb.org) under the accession codes 6OKC (C12AcpP–FabB),
6OKF (C16AcpP–FabB), 6OLT (C12AcpP–FabF), 6OKG (C16AcpP–FabF). All
parameter files for generating and running MD simulations are provided in the parm-
files folder in the online Source Data file. All original source data used for crosslinking
analysis reported in Fig. 6 and Supplementary Figs. 5, 6, and 8 are provided as a Source
Data file. All other data are available from the corresponding authors on reasonable
request.
Code availability
All MD simulation (AMBER 16 and AMBER 18) and analysis (PYTRAJ, CPPTRAJ) code
used herein is published and publicly available.
Received: 8 May 2019; Accepted: 6 March 2020;
References
1. Hertweck, C. The biosynthetic logic of polyketide diversity. Angew. Chem. Int.
Ed. 48, 4688–4716 (2009).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15455-x ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1727 | https://doi.org/10.1038/s41467-020-15455-x | www.nature.com/naturecommunications 13
2. Staunton, J. & Weissman, K. J. Polyketide biosynthesis: a millennium review.
Nat. Prod. Rep. 18, 380–416 (2001).
3. Beld, J., Lee, D. J. & Burkart, M. D. Fatty acid biosynthesis revisited: structure
elucidation and metabolic engineering. Mol. Biosyst. 11, 38–59 (2015).
4. White, S. W., Zheng, J., Zhang, Y.-M. & Rock, C. O. The structural biology of
type II fatty acid biosynthesis. Annu. Rev. Biochem. 74, 791–831 (2005).
5. Herbst, D. A., Townsend, C. A. & Maier, T. The architectures of iterative type
I PKS and FAS. Nat. Prod. Rep. https://doi.org/10.1039/C8NP00039E (2018).
6. Herbst, D. A. et al. The structural organization of substrate loading in iterative
polyketide synthases. Nat. Chem. Biol. 14, 474–479 (2018).
7. Herbst, D. A., Jakob, R. P., Zähringer, F. & Maier, T. Mycocerosic acid
synthase exemplifies the architecture of reducing polyketide synthases. Nature
531, 533–537 (2016).
8. Maier, T., Leibundgut, M. & Ban, N. The crystal structure of a mammalian
fatty acid synthase. Science. 321, 1315 LP-1322 (2008).
9. Maier, T., Leibundgut, M., Boehringer, D. & Ban, N. Structure and function of
eukaryotic fatty acid synthases. Q. Rev. Biophys. 43, 373–422 (2010).
10. Crosby, J. & Crump, M. P. The structural role of the carrier protein—active
controller or passive carrier. Nat. Prod. Rep. 29, 1111–1137 (2012).
11. Chen, A., Re, R. N. & Burkart, M. D. Type II fatty acid and polyketide
synthases: deciphering protein–protein and protein–substrate interactions.
Nat. Prod. Rep. 35, 1029–1045 (2018).
12. Kapur, S. et al. Reprogramming a module of the 6-deoxyerythronolide B
synthase for iterative chain elongation. Proc. Natl Acad. Sci. 109, 4110 LP-
4115 (2012).
13. Masoudi, A., Raetz, C. R. H., Zhou, P. & Pemble, C. W. IV Chasing acyl carrier
protein through a catalytic cycle of lipid A production. Nature 505, 422 (2013).
14. Nguyen, C. et al. Trapping the dynamic acyl carrier protein in fatty acid
biosynthesis. Nature 505, 427–431 (2014).
15. Lowry, B., Li, X., Robbins, T., Cane, D. E. & Khosla, C. A turnstile mechanism
for the controlled growth of biosynthetic intermediates on assembly line
polyketide synthases. ACS Cent. Sci. 2, 14–20 (2016).
16. Jiménez-Osés, G. et al. The role of distant mutations and allosteric regulation
on LovD active site dynamics. Nat. Chem. Biol. 10, 431 (2014).
17. Blatti, J. L. et al. Manipulating fatty acid biosynthesis in microalgae for biofuel
through protein–protein interactions. PLoS One 7, 1–12 (2012).
18. Ruppe, A. & Fox, J. M. Analysis of interdependent kinetic controls of fatty acid
synthases. ACS Catal. 8, 11722–11734 (2018).
19. Cronan, J. E. & Thomas, J. Bacterial fatty acid synthesis and its relationships
with polyketide synthetic pathways. Methods Enzymol. 459, 395–433 (2009).
20. Jenner, M. et al. Acyl-chain elongation drives ketosynthase substrate selectivity
in trans-acyltransferase polyketide synthases. Angew. Chem. Int. Ed. 54,
1817–1821 (2015).
21. Heil, C. S., Wehrheim, S. S., Paithankar, K. S. & Grininger, M. Fatty acid
biosynthesis: chain-length regulation and control. ChemBioChem 20,
2298–2321 (2019).
22. Klaus, M. & Grininger, M. Engineering strategies for rational polyketide
synthase design. Nat. Prod. Rep. 35, 1070–1081 (2018).
23. Gajewski, J. et al. Engineering fatty acid synthases for directed polyketide
production. Nat. Chem. Biol. 13, 363–365 (2017).
24. Zhu, Z. et al. Expanding the product portfolio of fungal type i fatty acid
synthases. Nat. Chem. Biol. 13, 360–362 (2017).
25. Fischer, M. & Grininger, M. Strategies in megasynthase engineering—fatty
acid synthases (FAS) as model proteins. Beilstein J. Org. Chem. 13, 1204–1211
(2017).
26. Gajewski, J., Pavlovic, R., Fischer, M., Boles, E. & Grininger, M. Engineering
fungal de novo fatty acid synthesis for short chain fatty acid production. Nat.
Commun. 8, 1–8 (2017).
27. Zhang, Y.-M., Hurlbert, J., White, S. W. & Rock, C. O. Roles of the active site
water, histidine 303, and phenylalanine 396 in the catalytic mechanism of the
elongation condensing enzyme of streptococcus pneumoniae. J. Biol. Chem.
281, 17390–17399 (2006).
28. von Wettstein-Knowles, P., Olsen, J. G., McGuire, K. A. & Henriksen, A. Fatty
acid synthesis. FEBS J. 273, 695–710 (2006).
29. Zhang, Y.-M., Wu, B., Zheng, J. & Rock, C. O. Key residues responsible for
acyl carrier protein and β-ketoacyl-acyl carrier protein reductase (FabG)
interaction. J. Biol. Chem. 278, 52935–52943 (2003).
30. Zhang, Y.-M. et al. Identification and analysis of the acyl carrier protein
(ACP) docking site on β-ketoacyl-ACP synthase III. J. Biol. Chem. 276,
8231–8238 (2001).
31. Tallorin, L. et al. Trapping of the enoyl-acyl carrier protein reductase-acyl
carrier protein interaction. J. Am. Chem. Soc. 138, 3962–3965 (2016).
32. Yu, X., Liu, T., Zhu, F. & Khosla, C. In vitro reconstitution and steady-state
analysis of the fatty acid synthase from Escherichia coli. Proc. Natl Acad. Sci.
108, 18643 LP-18648 (2011).
33. Dodge, G. J. et al. Structural and dynamical rationale for fatty acid
unsaturation in Escherichia coli. Proc. Natl. Acad. Sci. https://doi.org/10.1073/
pnas.1818686116 (2019).
34. Milligan, J. C. et al. Molecular basis for interactions between an acyl carrier
protein and a ketosynthase. Nat. Chem. Biol. 15, 669–671 (2019).
35. Marcella, A. M., Culbertson, S. J., Shogren-Knaak, M. A. & Barb, A. W.
Structure, high affinity, and negative cooperativity of the Escherichia coli holo-
(acyl carrier protein):holo-(acyl carrier protein) synthase complex. J. Mol. Biol.
429, 3763–3775 (2017).
36. Rafi, S. et al. Structure of acyl carrier protein bound to FabI, the FASII enoyl
reductase from escherichia coli. J. Biol. Chem. 281, 39285–39293 (2006).
37. Gora, A., Brezovsky, J. & Damborsky, J. Gates of enzymes. Chem. Rev. 113,
5871–5923 (2013).
38. Worthington, A. S. & Burkart, M. D. One-pot chemo-enzymatic synthesis of
reporter-modified proteins. Org. Biomol. Chem. 4, 44–46 (2006).
39. Worthington, A. S., Porter, D. F. & Burkart, M. D. Mechanism-based
crosslinking as a gauge for functional interaction of modular synthases. Org.
Biomol. Chem. 8, 1769–1772 (2010).
40. Finzel, K., Lee, D. J. & Burkart, M. D. Using modern tools to probe the
structure–function relationship of fatty acid synthases. ChemBioChem 16,
528–547 (2015).
41. D’Agnolo, G., Rosenfeld, I. S. & Vagelos, P. R. Multiple forms of beta-
ketoacyl-acyl carrier protein synthetase in Escherichia coli. J. Biol. Chem. 250,
5289–5294 (1975).
42. Garwin, J., Klages, A. & Cronan, J. Structural, enzymatic, and genetic studies
of beta-ketoacyl-acyl carrier protein synthases I and II of Escherichia coli. J.
Biol. Chem. 255, 11949–11956 (1980).
43. Wang, J. et al. Platensimycin is a selective FabF inhibitor with potent
antibiotic properties. Nature 441, 358–361 (2006).
44. Olsen, J. G., Kadziola, A., von Wettstein-Knowles, P., Siggaard-Andersen, M.
& Larsen, S. Structures of β-Ketoacyl-Acyl carrier protein synthase I
complexed with fatty acids elucidate its catalytic machinery. Structure 9,
233–243 (2001).
45. Zondlo, N. J. Aromatic-proline interactions: electronically tunable CH/π
interactions. Acc. Chem. Res. 46, 1039–1049 (2013).
46. Robbins, T., Liu, Y. C., Cane, D. E. & Khosla, C. Structure and mechanism of
assembly line polyketide synthases. Curr. Opin. Struct. Biol. 41, 10–18 (2016).
47. Dreier, J., Shah, A. N. & Khosla, C. Kinetic analysis of the actinorhodin
aromatic polyketide synthase. J. Biol. Chem. 274, 25108–25112 (1999).
48. Keatinge-Clay, A. T., Maltby, D. A., Medzihradszky, K. F., Khosla, C. &
Stroud, R. M. An antibiotic factory caught in action. Nat. Struct. Mol. Biol. 11,
888 (2004).
49. Hertweck, C., Luzhetskyy, A., Rebets, Y. & Bechthold, A. Type II polyketide
synthases: gaining a deeper insight into enzymatic teamwork. Nat. Prod. Rep.
24, 162–190 (2007).
50. Du, D., Katsuyama, Y., Shin-ya, K. & Ohnishi, Y. Reconstitution of a Type II
polyketide synthase that catalyzes polyene formation. Angew. Chem. Int. Ed.
57, 1954–1957 (2018).
51. Du, D. et al. Production of a novel amide-containing polyene by activating a
cryptic biosynthetic gene cluster in Streptomyces sp. MSC090213JE08.
ChemBioChem 17, 1464–1471 (2016).
52. Grammbitter, G. L. C. et al. An uncommon type II PKS catalyzes biosynthesis
of aryl polyene pigments. J. Am. Chem. Soc. https://doi.org/10.1021/
jacs.8b10776 (2019).
53. Cronan, J. E. The chain-flipping mechanism of ACP (acyl carrier protein)-
dependent enzymes appears universal. Biochem. J. 460, 157 LP-163 (2014).
54. Pappenberger, G., Schulz-Gasch, T., Kusznir, E., Müller, F. & Hennig, M.
Structure-assisted discovery of an aminothiazole derivative as a lead molecule
for inhibition of bacterial fatty-acid synthesis. Acta Crystallogr. Sect. D. 63,
1208–1216 (2007).
55. Henzler-Wildman, K. & Kern, D. Dynamic personalities of proteins. Nature
450, 964 (2007).
56. Trajtenberg, F. et al. Structural insights into bacterial resistance to cerulenin.
Febs J. 281, 2324–2338 (2014).
57. Robbins, T., Kapilivsky, J., Cane, D. E. & Khosla, C. Roles of conserved active
site residues in the ketosynthase domain of an assembly line polyketide
synthase. Biochemistry 55, 4476–4484 (2016).
58. Kosa, N. M., Haushalter, R. W., Smith, A. R. & Burkart, M. D. Reversible
labeling of native and fusion-protein motifs. Nat. Meth 9, 981–984 (2012).
59. Liu, H. & Naismith, J. H. An efficient one-step site-directed deletion, insertion,
single and multiple-site plasmid mutagenesis protocol. BMC Biotechnol. 8, 91
(2008).
60. Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25
years of image analysis. Nat. Methods 9, 671–675 (2012).
61. Battye, T. G. G., Kontogiannis, L., Johnson, O., Powell, H. R. & Leslie, A. G.
W. iMOSFLM: a new graphical interface for diffraction-image processing with
MOSFLM. Acta Crystallogr. D. Biol. Crystallogr. 67, 271–281 (2011).
62. Winn, M. D. et al. Overview of the CCP4 suite and current developments.
Acta Crystallogr. D. Biol. Crystallogr. 67, 235–242 (2011).
63. Lebedev, A. A. et al. JLigand: a graphical tool for the CCP4 template-restraint
library. Acta Crystallogr. D. Biol. Crystallogr. 68, 431–440 (2012).
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15455-x
14 NATURE COMMUNICATIONS |         (2020) 11:1727 | https://doi.org/10.1038/s41467-020-15455-x | www.nature.com/naturecommunications
64. Adams, P. D. et al. PHENIX: a comprehensive python-based system for
macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66,
213–221 (2010).
65. Roujeinikova, A. et al. Structural studies of fatty Acyl-(Acyl Carrier Protein)
thioesters reveal a hydrophobic binding cavity that can expand to fit longer
substrates. J. Mol. Biol. 365, 135–145 (2007).
66. Hanwell, M. D. et al. Avogadro: an advanced semantic chemical editor,
visualization, and analysis platform. J. Cheminform. 4, 1 (2012).
67. Gordon, J. C. et al. H++: a server for estimating pKas and adding missing
hydrogens to macromolecules. Nucleic Acids Res. 33, W368–71 (2005).
68. Myers, J., Grothaus, G., Narayanan, S. & Onufriev, A. A simple clustering
algorithm can be accurate enough for use in calculations of pKs in
macromolecules. Proteins 63, 928–938 (2006).
69. Anandakrishnan, R., Aguilar, B. & Onufriev, A. V. H++3.0: automating pK
prediction and the preparation of biomolecular structures for atomistic
molecular modeling and simulations. Nucleic Acids Res. 40, W537–W541 (2012).
70. Bashford, D. & Karplus, M. pKa’s of ionizable groups in proteins: atomic
detail from a continuum electrostatic model. Biochemistry 29, 10219–10225
(2002).
71. Maier, J. A. et al. ff14SB: improving the accuracy of protein side chain and
backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696–3713
(2015).
72. Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A.
Development and testing of a general AMBER force field. J. Comput. Chem.
25, 1157–1174 (2004).
73. Wang, J., Wang, W., Kollman, P. A. & Case, D. A. Automatic atom type and
bond type perception in molecular mechanical calculations. J. Mol. Graph.
Model. 25, 247260 (2006).
74. Bayly, C. I., Cieplak, P., Cornell, W. & Kollman, P. A. A well-behaved
electrostatic potential based method using charge restraints for deriving
atomic charges: the RESP model. J. Phys. Chem. 97, 10269–10280 (2002).
75. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M.
L. Comparison of simple potential functions for simulating liquid water. J.
Chem. Phys. 79, 926–935 (1998).
76. Case, D.A. et al., AMBER 2016 (University of California, San Francisco, 2016).
77. Ryckaert, J.-P., Ciccotti, G. & Berendsen, H. J. C. Numerical integration of the
cartesian equations of motion of a system with constraints: molecular
dynamics of n-alkanes. J. Comput. Phys. 23, 327–341 (1977).
78. Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: An N⋅log(N) method
for Ewald sums in large systems. J. Chem. Phys. 98, 10089–10092 (1998).
79. Liu, J., Li, D. & Liu, X. A simple and accurate algorithm for path integral
molecular dynamics with the Langevin thermostat. J. Chem. Phys. 145, 024103
(2016).
80. Roe, D. R., Thomas, E. & Cheatham, I. PTRAJ and CPPTRAJ: software for
processing and analysis of molecular dynamics trajectory data. J. Chem.
Theory Comput. 9, 3084–3095 (2013).
81. McGibbon, R. T. et al. MDTraj: a modern open library for the analysis
of molecular dynamics trajectories. Biophys. J. 109, 1528–1532 (2015).
82. Humphrey, W., Dalke, A. & Schulten, K. VMD—visual molecular dynamics. J.
Molec. Graph. 14, 33–38 (1996).
Acknowledgements
This research was supported by National Science Foundation Grant EEC-0813570 (to J.P.N.)
and NIH GM095970 (to M.D.B.). NIH grant T32 GM008326 for support of J.T.M. NIH
Grant T32 GM112584 for support of T.G.B. T.D.D. is a San Diego IRACDA Postdoctoral
Fellow supported by NIH K12 GM068524. Portions of the work were also funded by the
Arthur and Julie Woodrow Chair at the Salk Institute (to J.P.N.) and the Howard Hughes
Medical Institute (to J.P.N.). The authors thank Dr Gordon Louie for assistance in x-ray data
collection, processing, and refinement and Marianne Bowman for assistance with protein
crystallization. The authors also thank Dr Laetitia Misson for assistance with data analysis.
We further acknowledge the following organizations for support of the computer simulation
work reported herein: NIH GM31749 (to J.A.M.) and the San Diego Supercomputing Center
(to J.A.M.).
Author contributions
J.J.L., J.A.M, M.D.B., and J.P.N. designed and supervised the project. T.D.D. synthesized
probe molecules. J.T.M, W.E.K., T.G.B., and A.C. purified protein, optimized cross-
linking, carried out crystallization, and obtained crystals. J.T.M. collected x-ray diffrac-
tion data and refined and analyzed crystallographic models. J.T.M designed and
produced gating mutants. W.E.K. and A.C. performed crosslinking assays. A.P. per-
formed MD simulations. A.P., J.T.M., and J.A.M analyzed simulation data. J.T.M., A.P.,
J.J.L., J.A.M., M.D.B., and J.P.N. wrote the manuscript. All authors edited the manuscript.
W.E.K., T.D.D., A.C., and T.G.B. contributed equally to this work.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41467-
020-15455-x.
Correspondence and requests for materials should be addressed to J.P.N. or M.D.B.
Peer review information Nature Communications thanks Martin Grininger, and the
other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer
reviewer reports are available.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2020
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15455-x ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1727 | https://doi.org/10.1038/s41467-020-15455-x | www.nature.com/naturecommunications 15
